NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Targacept, Inc. (NASDAQ: TRGT)
TRGT Technical Analysis
5
As on 20th Aug 2015 TRGT Share Price closed @ 0.96 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.54 & Strong Sell for SHORT-TERM with Stoploss of 2.60 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TRGT Share Price
Open | 1.35 | Change | Price | % |
High | 1.35 | 1 Day | -0.68 | -41.46 |
Low | 0.82 | 1 Week | 0.00 | 0.00 |
Close | 0.96 | 1 Month | 0.00 | 0.00 |
Volume | 197793 | 1 Year | 0.00 | 0.00 |
52 Week High 274.40 | 52 Week Low 87.16 |
NASDAQ USA Most Active Stocks
YHOO | 52.58 | 0.00% |
FNFG | 10.18 | -0.20% |
DELL | 13.86 | 0.22% |
RFMD | 16.59 | -2.07% |
MU | 44.31 | 6.39% |
RIMM | 13.03 | 0.39% |
BBEP | 0.12 | 0.00% |
GTAT | 0.44 | 0.00% |
SUSQ | 14.20 | -0.77% |
INTC | 45.49 | 2.52% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
TRGT Daily Charts |
TRGT Intraday Charts |
Whats New @ Bazaartrend |
TRGT Free Analysis |
|
TRGT Important Levels Intraday
SUPPORT | 0.00 |
SUPPORT | 0.00 |
RESISTANCE | 1.45 |
RESISTANCE | 1.25 |
SUPPORT | 0.67 |
SUPPORT | 0.47 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
TRGT Target for Month January
4th UP TARGET | 0 |
3rd UP TARGET | 0 |
2nd UP TARGET | 0 |
1st UP TARGET | 0 |
1st DOWN TARGET | 0 |
2nd DOWN TARGET | 0 |
3rd DOWN TARGET | 0 |
4th DOWN TARGET | 0 |
TRGT Weekly Target
4th UP TARGET | 0.00 |
3rd UP TARGET | 0.00 |
2nd UP TARGET | 0.00 |
1st UP TARGET | 0.00 |
1st DOWN TARGET | 0.00 |
2nd DOWN TARGET | 0.00 |
3rd DOWN TARGET | 0.00 |
4th DOWN TARGET | 0.00 |
TRGT Target for Year 2021
4th UP TARGET | 0 |
3rd UP TARGET | 0 |
2nd UP TARGET | 0 |
1st UP TARGET | 0 |
1st DOWN TARGET | 0 |
2nd DOWN TARGET | 0 |
3rd DOWN TARGET | 0 |
4th DOWN TARGET | 0 |
Targacept, Inc. ( NASDAQ USA Symbol : TRGT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TRGT Other Details
Segment | EQ | |
Market Capital | 139070800.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
TRGT Address
![]() |
100 North Main Street Suite 1510 Winston-Salem, NC 27101 United States Phone: 336-480-2100 Fax: 336-480-2107 |
TRGT Latest News
TRGT Business Profile
Targacept, Inc. is a biopharmaceutical company. The Company is engaged in the design, discovery and development of NNR Therapeutics for the treatment of diseases and disorders of the nervous system. The Company's NNR Therapeutics target neuronal nicotinic receptors (NNRs). As of December 31, 2011, the Company had multiple clinical-stage product candidates and preclinical programs in areas. The Company's drug discovery activities utilize computer-based molecular design methodologies and biological and chemical data for a library of diverse compounds developed and collected. The Company refers to these technologies collectively as Pentad. Its clinical-stage product candidates include TC-5214, TC-5619, TC-6987, AZD3480 (TC-1734), AZD1446 (TC-6683), TC-6499 and TC-6987.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service